NasdaqCM:AHCOHealthcare
AdaptHealth (AHCO) EPS Loss In Q4 2025 Tests Profitability Turnaround Narrative
AdaptHealth (AHCO) has just posted its latest results with Q4 2025 revenue of US$846.3 million and a basic EPS loss of US$0.74, setting the tone for how investors will read the Q1 2026 update. The company has seen quarterly revenue move from US$856.6 million in Q4 2024 to US$846.3 million in Q4 2025, while EPS shifted from US$0.34 to a loss of US$0.74 over the same period. This puts the focus squarely on earnings quality. With the stock trading at US$11.75, investors may pay close attention...